3iiq: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:3iiq.png|left|200px]] | [[Image:3iiq.png|left|200px]] | ||
| Line 20: | Line 19: | ||
==About this Structure== | ==About this Structure== | ||
[[3iiq]] is a 4 chain structure with sequence from [http://en.wikipedia.org/wiki/Escherichia_coli Escherichia coli] and [http://en.wikipedia.org/wiki/Streptomyces_sp. Streptomyces sp.]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3IIQ OCA]. | |||
==Reference== | ==Reference== | ||
<ref group="xtra">PMID: | <ref group="xtra">PMID:019655811</ref><references group="xtra"/> | ||
[[Category: Escherichia coli]] | [[Category: Escherichia coli]] | ||
[[Category: Signal peptidase I]] | [[Category: Signal peptidase I]] | ||
[[Category: Streptomyces sp.]] | |||
[[Category: Paetzel, M.]] | [[Category: Paetzel, M.]] | ||
[[Category: Antibiotic]] | [[Category: Antibiotic]] | ||
[[Category: | [[Category: Biaryl bridge]] | ||
[[Category: Hydrolase-antibiotic-inhibitor complex]] | |||
[[Category: Lipopeptide]] | |||
[[Category: Morpholino beta-sultam]] | |||
[[Category: Hydrolase | [[Category: Peptidase]] | ||
[[Category: Ser/lys dyad]] | |||
[[Category: | |||
[[Category: Morpholino]] | |||
[[Category: | |||
[[Category: Ser/lys dyad | |||
[[Category: Serine protease]] | [[Category: Serine protease]] | ||
Revision as of 04:36, 27 July 2011
Crystallographic analysis of bacterial signal peptidase in ternary complex with Arylomycin A2 and a beta-sultam inhibitor
Template:ABSTRACT PUBMED 19655811
About this Structure
3iiq is a 4 chain structure with sequence from Escherichia coli and Streptomyces sp.. Full crystallographic information is available from OCA.
Reference
- Luo C, Roussel P, Dreier J, Page MG, Paetzel M. Crystallographic analysis of bacterial signal peptidase in ternary complex with arylomycin A2 and a beta-sultam inhibitor. Biochemistry. 2009 Sep 29;48(38):8976-84. PMID:19655811 doi:10.1021/bi9009538
